Literature DB >> 19670115

The role of positron emission tomography/computed tomography in the diagnosis of pleural diseases.

A Orki1, O Akin, A E Tasci, H Ciftci, S Urek, O Falay, C A Kutlu.   

Abstract

BACKGROUND: The aim of the study was to assess the role of F-18 fluoro-2-D-deoxyglucose positron emission tomography ( (18)FDG-PET)/computed tomography (CT) in patients with undiagnosed pleural diseases and to compare the findings with those of invasive diagnostic procedures.
METHODS: The study included 83 patients with pleural lesions (63 with pleural effusion; 20 with pleural thickening) on CT scan performed between November 2005 and December 2007. The study group consisted of 63 males and 20 females; their median age was 47 years. PET-CT scan was performed for all patients before surgery. A maximum standard uptake value greater than 3.0 was accepted as positive for malignancy. For histopathological diagnosis, video-assisted thoracoscopic surgery was performed in 76 patients and a mini-thoracotomy was performed for the remaining 7 patients.
RESULTS: Postoperative histopathological examination revealed malignancy in 44 cases, 25 of which were malignant mesothelioma; the remaining 39 cases were benign. There were no false negative results, but two false positive results (tuberculosis). PET-CT scanning had 100 % sensitivity, 94.8 % specificity and 97.5 % accuracy.
CONCLUSION: Our study suggests that PET-CT may be an effective tool for the differentiation of benign and malignant pleural diseases. We believe that PET/CT may prevent redundant surgical procedures in young patients who are SUVmax negative. Georg Thieme Verlag KG Stuttgart New York.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19670115     DOI: 10.1055/s-2008-1039314

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  9 in total

1.  Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival.

Authors:  Oleg Mironov; Nicole M Ishill; Svetlana Mironov; Hebert Alberto Vargas; Junting Zheng; Chaya S Moskowitz; Yukio Sonoda; Ralph S Papas; Dennis S Chi; Hedvig Hricak
Journal:  Radiology       Date:  2010-12-30       Impact factor: 11.105

Review 2.  Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.

Authors:  Sandip Basu; Babak Saboury; Drew A Torigian; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

3.  Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease.

Authors:  Seiji Kurata; Masatoshi Ishibashi; Koichi Azuma; Hayato Kaida; Shinzo Takamori; Kiminori Fujimoto; Maiko Kobayashi; Yasumitsu Hirose; Hisamichi Aizawa; Naofumi Hayabuchi
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

Review 4.  Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

5.  Thoracic metastasis in advanced ovarian cancer: comparison between computed tomography and video-assisted thoracic surgery.

Authors:  Oleg Mironov; Evis Sala; Svetlana Mironov; Harpreet Pannu; Dennis S Chi; Hedvig Hricak
Journal:  J Gynecol Oncol       Date:  2011-12-05       Impact factor: 4.401

Review 6.  Pleural effusion: diagnosis, treatment, and management.

Authors:  Vinaya S Karkhanis; Jyotsna M Joshi
Journal:  Open Access Emerg Med       Date:  2012-06-22

Review 7.  Diagnostic Imaging and workup of Malignant Pleural Mesothelioma.

Authors:  Luciano Cardinale; Francesco Ardissone; Dario Gned; Nicola Sverzellati; Edoardo Piacibello; Andrea Veltri
Journal:  Acta Biomed       Date:  2017-08-23

8.  The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.

Authors:  Yajuan Sun; Hongjuan Yu; Jingquan Ma; Peiou Lu
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

Review 9.  Clinical staging of malignant pleural mesothelioma: current perspectives.

Authors:  Maria Bonomi; Costantino De Filippis; Egesta Lopci; Letizia Gianoncelli; Giovanna Rizzardi; Eleonora Cerchiaro; Luigi Bortolotti; Alessandro Zanello; Giovanni Luca Ceresoli
Journal:  Lung Cancer (Auckl)       Date:  2017-08-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.